$OGEN
ORAGENICS INC

2017 Q1 Form 10-K Financial Statement

#000119312517058912 Filed on February 27, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q4 2015 Q4
Revenue $0.00 $0.00 $240.2K
YoY Change -100.0% 8.95%
Cost Of Revenue $0.00 $0.00
YoY Change -100.0%
Gross Profit $0.00 $0.00
YoY Change -100.0%
Gross Profit Margin 0.0%
Selling, General & Admin $870.0K $930.0K $850.0K
YoY Change -12.51% 9.41% 4.94%
% of Gross Profit
Research & Development $1.122M $1.780M $1.340M
YoY Change -8.36% 32.84% 143.64%
% of Gross Profit
Depreciation & Amortization $20.00K $20.00K $20.00K
YoY Change 0.0% 0.0% 100.0%
% of Gross Profit
Operating Expenses $1.988M $2.708M $2.196M
YoY Change -4.19% 23.32% 61.44%
Operating Profit -$1.988M -$2.708M -$2.196M
YoY Change -4.19% 23.32% 78.5%
Interest Expense $801.00 $20.00K -$20.00K
YoY Change 3.89% -200.0% -300.0%
% of Operating Profit
Other Income/Expense, Net $5.081K $10.00K $0.00
YoY Change 685.32%
Pretax Income -$1.983M -$2.680M -$2.220M
YoY Change -4.41% 20.72% 81.97%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.983M -$2.675M -$2.219M
YoY Change -3.89% 20.52% 81.39%
Net Earnings / Revenue -923.85%
Basic Earnings Per Share
Diluted Earnings Per Share -$402.4K -$542.7K -$590.4K
COMMON SHARES
Basic Shares Outstanding 49.27M shares 49.11M shares 36.48M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q4 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.180M $4.080M $5.080M
YoY Change -35.31% -19.69% -51.39%
Cash & Equivalents $2.175M $4.081M $5.083M
Short-Term Investments
Other Short-Term Assets $110.0K $140.0K $210.0K
YoY Change -42.11% -33.33% 75.0%
Inventory $0.00 $321.5K
Prepaid Expenses
Receivables $0.00 $21.12K
Other Receivables $0.00
Total Short-Term Assets $2.281M $4.222M $5.638M
YoY Change -40.51% -25.12% -48.86%
LONG-TERM ASSETS
Property, Plant & Equipment $69.43K $87.46K $140.7K
YoY Change -43.26% -37.82% 28.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $69.43K $87.46K $140.7K
YoY Change -43.26% -37.82% 28.69%
TOTAL ASSETS
Total Short-Term Assets $2.281M $4.222M $5.638M
Total Long-Term Assets $69.43K $87.46K $140.7K
Total Assets $2.351M $4.309M $5.778M
YoY Change -40.59% -25.43% -48.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.100M $1.280M $970.0K
YoY Change 11.11% 31.96% 36.62%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $60.00K $70.00K $60.00K
YoY Change -25.0% 16.67% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.165M $1.343M $1.047M
YoY Change 7.58% 28.27% 31.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.165M $1.343M $1.047M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.170M $1.340M $1.050M
YoY Change 8.33% 27.62% 31.25%
SHAREHOLDERS EQUITY
Retained Earnings -$96.65M -$94.67M -$87.66M
YoY Change 7.73% 8.0% 15.42%
Common Stock $97.84M $97.62M $92.39M
YoY Change 5.66% 5.67% 7.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.186M $2.966M $4.731M
YoY Change
Total Liabilities & Shareholders Equity $2.351M $4.309M $5.778M
YoY Change -40.59% -25.43% -48.09%

Cashflow Statement

Concept 2017 Q1 2016 Q4 2015 Q4
OPERATING ACTIVITIES
Net Income -$1.983M -$2.675M -$2.219M
YoY Change -3.89% 20.52% 81.39%
Depreciation, Depletion And Amortization $20.00K $20.00K $20.00K
YoY Change 0.0% 0.0% 100.0%
Cash From Operating Activities -$1.900M -$1.980M -$1.600M
YoY Change 17.33% 23.75% 35.59%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.951K 940.0K -50.00K
YoY Change -85.42% -1980.0% 0.0%
NET CHANGE
Cash From Operating Activities -1.900M -1.980M -1.600M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities -4.951K 940.0K -50.00K
Net Change In Cash -1.905M -1.040M -1.650M
YoY Change 15.22% -36.97% 25.0%
FREE CASH FLOW
Cash From Operating Activities -$1.900M -$1.980M -$1.600M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$1.980M -$1.600M
YoY Change 23.75% 46.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49274219 shares
CY2009Q2 ogen Net Operating Loss Carryforwards Pre Change Annual Limitation
NetOperatingLossCarryforwardsPreChangeAnnualLimitation
417000
CY2016Q2 dei Entity Public Float
EntityPublicFloat
7482815
CY2013Q4 ogen Net Operating Loss Carryforwards Pre Change Annual Limitation
NetOperatingLossCarryforwardsPreChangeAnnualLimitation
3540000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10448921
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
10336148
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.03
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1354652
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
820865 shares
CY2015Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
302107
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
831029
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
33896
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1447913
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
513106
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39858540 shares
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
9596
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39858540 shares
CY2015Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
25500
CY2015Q4 us-gaap Assets
Assets
5778379
CY2015Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4833355
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
4188
CY2015Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
67919
CY2015Q4 us-gaap Assets Current
AssetsCurrent
5637728
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31199403
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
530
CY2015Q4 us-gaap Disposal Group Including Discontinued Operation Deferred Revenue
DisposalGroupIncludingDiscontinuedOperationDeferredRevenue
14215
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
92347134
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1400
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5083355
CY2015Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Interest
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInterest
134222
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
39859
CY2015Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
279997
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
22827
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
155506
CY2015Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
345074
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31199403
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
30701734
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
153461
CY2015Q4 us-gaap Inventory Gross
InventoryGross
382169
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Inventory Net
InventoryNet
321509
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5778379
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1047354
CY2015Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
5923
CY2015Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
152973
CY2015Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
222785
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
60660
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
140651
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1588564
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
4731025
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.00
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1708466
CY2016Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
25500
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49114219 shares
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87655968
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
209299
CY2015Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
63352
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1471031 shares
CY2015Q4 ogen Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Restricted Stock
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRestrictedStock
42590
CY2015Q4 ogen Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
0
CY2015Q4 ogen Deferred Tax Assets Tax Deferred Expense Uniform Capitalization
DeferredTaxAssetsTaxDeferredExpenseUniformCapitalization
5158
CY2016Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
524620
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1277066
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
30563
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Compensated Absences
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences
35132
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1518692
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
513106
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49114219 shares
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
9596
CY2016Q4 us-gaap Assets
Assets
4309166
CY2016Q4 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
120000000 shares
CY2016Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
3830618
CY2016Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
93361
CY2016Q4 us-gaap Assets Current
AssetsCurrent
4221704
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
33787134
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Disposal Group Including Discontinued Operation Deferred Revenue
DisposalGroupIncludingDiscontinuedOperationDeferredRevenue
0
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
97616444
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4080618
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
49114
CY2016Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
461344
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1912538 shares
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
175584 shares
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
169239
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
33787134
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
33186710
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
584986
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
87663000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
9399
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
193957
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Inventory Net
InventoryNet
0
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4309166
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1343443
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
183234
CY2016Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
198396
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87462
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1606154
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.75
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
2965723
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
365744
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.28
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
648163 shares
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1875337
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-94669272
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
291015 shares
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
141086
CY2016Q4 us-gaap Short Term Non Bank Loans And Notes Payable
ShortTermNonBankLoansAndNotesPayable
66377
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4000000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1621523 shares
CY2016Q4 ogen Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Restricted Stock
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostRestrictedStock
42590
CY2016Q4 ogen Share Based Compensation Arrangement By Share Based Payment Award Shares Issued To Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedToDate
2087462 shares
CY2016Q4 ogen Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
3002
CY2015Q1 ogen Class Of Warrant Expired Weighted Average Exercise Price
ClassOfWarrantExpiredWeightedAverageExercisePrice
2.00
CY2015Q1 ogen Class Of Warrant Expired
ClassOfWarrantExpired
2170925 shares
CY2016Q4 ogen Number Of Common Stock Outstanding If Warrants And Stock Options Exercised
NumberOfCommonStockOutstandingIfWarrantsAndStockOptionsExercised
50911326 shares
CY2009Q2 ogen Net Operating Loss Carryforward Limitation On Use Percentage Ownership Change Minimum
NetOperatingLossCarryforwardLimitationOnUsePercentageOwnershipChangeMinimum
0.50 pure
CY2013 ogen Net Operating Loss Carryforward Limitation On Use Percentage Ownership Change Minimum
NetOperatingLossCarryforwardLimitationOnUsePercentageOwnershipChangeMinimum
0.50 pure
CY2013 ogen Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
14900000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2015 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5450671
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2015 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
85105
CY2015 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
770704
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3047354
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
71152
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
0
CY2015 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
128745
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4700
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
24634
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4271483
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2015 us-gaap Interest Paid
InterestPaid
5241
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
288055
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-152564
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-59214
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
776
CY2015 us-gaap Gross Profit
GrossProfit
0
CY2015 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
128745
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3981853
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4271483
CY2015 us-gaap Operating Expenses
OperatingExpenses
11780864
CY2015 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-11711333
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11840078
CY2015 us-gaap Interest Expense
InterestExpense
76668
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5189490
CY2015 us-gaap Notes Assumed1
NotesAssumed1
158462
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-159950
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-68573
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-11780864
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-101231
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1280
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
348694
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
21378
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
264000
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4271483
CY2015 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
35887
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.32
CY2015 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-425121
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
102511
CY2015 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1280
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0227 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.49 pure
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.31
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
5071506
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.71
CY2015 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
325361
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
353814
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5071506
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8733510
CY2015 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
770704
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
928500 shares
CY2015 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-159950
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0214 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
278334 shares
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2015 us-gaap Restricted Stock Expense
RestrictedStockExpense
264000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.47 pure
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36656257 shares
CY2015 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-11840078
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2015 ogen Par Value Of Restricted Shares Issued
ParValueOfRestrictedSharesIssued
200
CY2015 ogen Common Stock Issued During Period Par Value For Warrants Exercise
CommonStockIssuedDuringPeriodParValueForWarrantsExercise
99
CY2015 ogen Technology Access Fee Paid In Convertible Note Payable To Shareholder
TechnologyAccessFeePaidInConvertibleNotePayableToShareholder
5000000
CY2012 ogen Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
13000000
CY2016 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
Less than a 50%
CY2016 dei Entity Registrant Name
EntityRegistrantName
ORAGENICS INC
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001174940
CY2016 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-948582
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2016 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
1453744
CY2016 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-54155
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
472780
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3787855
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Concentrations</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> In June of 2016, the Company sold its consumer probiotics business (See Note 5), as such the Company is no longer dependent on key suppliers to continue to operate the consumer probiotics business.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company maintains cash accounts in commercial banks, which may, at times, exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash and cash equivalents. As of December&#xA0;31, 2016, the uninsured portion of this balance was $3,830,618. As of December&#xA0;31, 2015, the uninsured portion of this balance was $4,833,355.</p> </div>
CY2016 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.03 pure
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
75044
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
0
CY2016 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
30268
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4798
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
33237
CY2016 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
464048
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M6D
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2587731
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2016 us-gaap Interest Paid
InterestPaid
4116
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
185607
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-134222
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
45189
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14013
CY2016 us-gaap Gross Profit
GrossProfit
0
CY2016 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1484012
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2384532
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2587731
CY2016 us-gaap Operating Expenses
OperatingExpenses
8542505
CY2016 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.03
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-7013304
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8497316
CY2016 us-gaap Interest Expense
InterestExpense
4116
CY2016 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
250000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7075085
CY2016 us-gaap Notes Assumed1
NotesAssumed1
161125
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4451484
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-229338
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-8542505
CY2016 us-gaap Notes Issued1
NotesIssued1
2000000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1675019
CY2016 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
1450000
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3126
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
446037
CY2016 us-gaap Operating Loss Carryforwards Expiration Date
OperatingLossCarryforwardsExpirationDate
2036-12-31
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
40090
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
151200
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2587731
CY2016 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
36030
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.19
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-254584
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27179
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2640147
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2198
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0240 pure
CY2016 us-gaap Stockholders Equity Other
StockholdersEquityOther
-1969437
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements in conformity with US&#xA0;GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The principal areas of estimation reflected in the financial statements are anticipated milestone payments, stock based compensation, valuation of warrants, and income tax valuation allowance. Inventory obsolescence reserve, sales returns and allowances and the allowance for doubtful accounts were the principal areas of estimation that had been reflected in the financial statements related to discontinued operations.</p> </div>
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.47 pure
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.69
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.40
CY2016 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
14438
CY2016 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
572786
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
166871
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2640147
CY2016 dei Trading Symbol
TradingSymbol
OGEN
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4754650
CY2016 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Guaranteed Rights of Return</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> In June of 2016, the Company sold its consumer probiotics business (See Note 5). The Company had granted guaranteed rights of return to two dental distributors in connection with its consumer probiotics business. The Company deferred recognition of revenue on these accounts until either the distributor provided notification to the Company that the product had been sold to the end consumer or the guaranteed right of return period expired. Once notification was received and verified, the Company recorded revenue in that accounting period. As a result of the sale of the consumer probiotics business (See Note 5), no amounts are shown for deferred revenue as of December&#xA0;31, 2016. The Company had <font style="WHITE-SPACE: nowrap"><font style="WHITE-SPACE: nowrap">$-0-</font></font> and $14,215 of revenue deferred under guaranteed rights of return arrangements included in current liabilities of discontinued operations in the balance sheets as of December&#xA0;31, 2016 and December&#xA0;31, 2015, respectively.</p> </div>
CY2016 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
487218
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
725250 shares
CY2016 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-158100
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0159 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
574758 shares
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2016 us-gaap Restricted Stock Expense
RestrictedStockExpense
151200
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.42 pure
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44600197 shares
CY2016 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-8497316
CY2016 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2016 ogen Number Of Dental Distributor With Guaranteed Rights Of Returns
NumberOfDentalDistributorWithGuaranteedRightsOfReturns
2 Customer
CY2016 ogen Cash And Cash Equivalents Maturity Date Description
CashAndCashEquivalentsMaturityDateDescription
Three months or less
CY2016 ogen Par Value Of Restricted Shares Issued
ParValueOfRestrictedSharesIssued
230
CY2016 ogen Proceeds From Issuance Of Common Stock Gross
ProceedsFromIssuanceOfCommonStockGross
4666667
CY2016 ogen Par Value Of Restricted Shares Forfeited
ParValueOfRestrictedSharesForfeited
20
CY2016 ogen Proceeds From Payment Of Stock Subscription Receivable
ProceedsFromPaymentOfStockSubscriptionReceivable
1969437
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
78573
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
1374858
CY2015Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-1292777
CY2015Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.04
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
13928
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
6344223
CY2015Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-6335471
CY2015Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.17
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2016Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
11113
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
2074645
CY2016Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-2062885
CY2016Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.05
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2016Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
1420947
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
1733282
CY2016Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.04
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-312615
CY2016Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.04
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2015Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
36419
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
1865934
CY2015Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2016Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
42566
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
2026670
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-1863676
CY2015Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.05
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2016Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-1963007
CY2016Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.04
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2015Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-174
CY2015Q4 us-gaap Operating Expenses
OperatingExpenses
2195851
CY2015Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-2219409
CY2015Q4 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.06
CY2016Q4 us-gaap Sales Revenue Net
SalesRevenueNet
0
CY2016Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
9386
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
2707908
CY2016Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.00
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-2674797
CY2016Q4 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.05

Files In Submission

Name View Source Status
0001193125-17-058912-index-headers.html Edgar Link pending
0001193125-17-058912-index.html Edgar Link pending
0001193125-17-058912.txt Edgar Link pending
0001193125-17-058912-xbrl.zip Edgar Link pending
d315487d10k.htm Edgar Link pending
d315487dex231.htm Edgar Link pending
d315487dex311.htm Edgar Link pending
d315487dex312.htm Edgar Link pending
d315487dex321.htm Edgar Link pending
d315487dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ogen-20161231.xml Edgar Link completed
ogen-20161231.xsd Edgar Link pending
ogen-20161231_cal.xml Edgar Link unprocessable
ogen-20161231_def.xml Edgar Link unprocessable
ogen-20161231_lab.xml Edgar Link unprocessable
ogen-20161231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending